Objective: To compare the value of body fat mass (%FM) to indirect measures of general (body mass index (BMI)) and central adiposity (waist circumference (WC); waist-to-height ratio (WC/ht)) for the prediction of overweight-and obesity-related metabolic risk in a study population with a high prevalence of metabolic syndrome (MSX). Methods: BMI, WC, WC/ht, body composition (by air-displacement plethysmography) and metabolic risk factors: triglycerides, cholesterol, HDL-cholesterol (HDL-C), uric acid, systolic blood pressure (BPsys), insulin resistance by homeostasis model assessment (HOMA-IR) and C-reactive protein (CRP) were measured in 335 adults (191 women, 144 men; mean age 53 713.9 years, prevalence of MSX 30%). Results: When compared with BMI and WC, %FM showed weaker associations with metabolic risk factors, except for CRP and BPsys in men. In women, HDL-C and HOMA-IR showed the closest correlations with BMI. For all other risk factors, WC or WC/ht were the best predictors in both sexes. Differences in the strength of correlations between an obesity index and different risk factors exceeded the differences observed between all obesity indices within one risk factor. In stepwise multiple regression analyses, WC/ht was the main predictor of metabolic risk in both sexes combined. However, analysis of the area under receiver operating characteristic curves for prediction of the prevalence of X2 component traits of the MSX revealed a similar accuracy of all obesity indices. Conclusions: At the population level, measurement of body FM has no advantage over BMI and WC in the prediction of obesityrelated metabolic risk. Although measures of central adiposity (WC, WC/ht) tended to show closer associations with risk factors than measures of general adiposity, the differences were small and depended on the type of risk factor and sex, suggesting an equivalent value of methods.
Introduction
Different obesity indices (i.e. body mass index (BMI) and waist circumference (WC)) are used to define the metabolic syndrome (MSX). The use of BMI was recommended by the WHO, whereas WC was included in the National Cholesterol Education Program (NCEP) definition of MSX. 1, 2 This contributes to differences in the prevalence and incidence of MSX reported in several studies. [3] [4] [5] [6] While the choice between the two parameters remains a matter of an ongoing debate, direct assessment of fat mass (FM) may be a better index of obesity-related health risk. Accordingly, on the occasion of the Sixth International Symposium 'In Vivo Body Composition Studies' in Rome (2002), the experts argued that BMI is an inaccurate reflection of %FM and we therefore need to establish larger databases on directly assessed %FM and cardiovascular risk factors or other end points like all-cause mortality in order to develop more appropriate normal values for %FM. 7 However, studies comparing the values of BMI and %FM in the prediction of metabolic risk are contradictory. [8] [9] [10] [11] [12] [13] [14] [15] Some authors found that when compared to %FM BMI was similar or even more closely associated to cardiovascular risk factors, for example, lipid profile, blood pressure or insulin resistance (IR). [8] [9] [10] [11] [12] By contrast, the value of %FM exceeded BMI in other studies. [13] [14] [15] One explanation of these discrepant results may be that the data suffer from methodological drawbacks of field methods used for body composition analysis (e.g. bioelectrical impedance analysis or anthropometry). While the value of %FM remains to be demonstrated, WC, a marker of central obesity, is recommended for assessment of obesity-related health risk. [16] [17] [18] [19] [20] When compared with WC alone, a closer association of waist-to-height ratio (WC/ht) to cardiovascular risk factors has been observed by some authors. [21] [22] [23] [24] However, there is no consensus whether WC should be adjusted for body height. In addition, the nature of this association remains causally enigmatic and the use of WC/ht as an obesity index is therefore contentious. The present study sets out to investigate whether densitometrically measured %FM is more sensitive and specific and more closely associated to metabolic risk profile than BMI or WC or WC adjusted for body height. Body composition analysis was also used to investigate the plausibility of the association between WC/ht and risk factors.
Subjects and methods

Study population and design
Study sample was taken from adults of the Kiel Obesity Prevention Study (KOPS) -Family Study. 25 The main objective of this ongoing three-generation trial is to assess the contribution of genetic factors to the MSX. In all, 335 subjects (191 women and 144 men) were recruited by advertisements in local newspapers, by notice-board postings and writing to families that are continuously followed up as a KOPS subcohort. Inclusion criteria for study participation are at least two grandparents taking part as well as one family member with overweight or obesity. All participants were of Caucasian descent. The study protocol was approved by the local ethical committee of the Christian-Albrechts-Universität Kiel. Each subject provided informed written consent before participation.
Anthropometric measurements and body composition analysis
Body weight was measured to the nearest 0.1 kg on an electronic scale coupled to the BOD-POD s Body Composition System (Life Measurement Instruments, Concord, CA, USA). Height was measured on a stadiometer to the nearest 0.5 cm. WC was measured to the nearest 0.5 cm midway between the lowest rib and the iliac creast, while the subject was at minimal respiration. Air-displacement plethysmography was performed by the BOD-POD s device as described in detail elsewhere. 26 Briefly, subjects were measured in tight-fitting underwear and a swimming cap. Two repeated measurements of body volume were performed and averaged. The measured thoracic lung volume was subtracted from body volume. BOD-POD s software was used to calculate body density as body weight divided by body volume and %FM using Siri's equation. 27 Fat-free mass (FFM) (kg) was calculated accordingly: weight (kg) -FM (kg).
In our hands, coefficients of variation for repeated measurements performed by six different observers were 3.6% for WC, 2.4% for %FM and 0.8% for BMI, respectively.
Metabolic variables
Blood pressure measurements were obtained with the subject in a seated position by using a standard manual sphygmomanometer. Blood samples were obtained after a minimum 8-h fast and metabolic parameters were analyzed by standard procedures. Briefly, plasma glucose was assayed by using a hexokinase enzymatic method. Cholesterol and triacylglycerol concentrations were measured enzymatically by hydrolyzing cholesterol ester and triacylglcerol to cholesterol and glycerol, respectively. HDL-cholesterol (HDL-C) was analyzed in the supernatant after precipitation of lipoproteins. Plasma insulin was measured by immunoradiometric assay (all kits and standards by Konelab-Cooperation, Espoo, Finland). The homeostasis model assessment (HOMA-IR) 28 (1) hypertriglyceridemia: X150 mg/dl (X1.69 mmol/l), (2) low HDL-C: o40 mg/dl (o1.04 mmol/l) in men or o50 mg/dl (o1.29 mmol/l) in women, (3) high blood pressure: X130/85 mmHg, (4) high fasting plasma glucose: X110 mg/dl (X6.1 mmol/l) and (5) abdominal obesity: WC 488 cm in women, and 4102 cm in men. Participants who reported a history of physiciandiagnosed diabetes, hypertension, hyperlipidemia or hyperuricemia and used antihypertensive, antidiabetic (insulin or oral agents), lipid lowering or uricosuric agents were defined as having high blood pressure, high fasting glucose, elevated plasma lipids or uric acid, respectively. Those subjects were excluded from correlation and regression analyses.
transformation. ANOVA was used to compare means between sexes. Relationships between variables were examined using Pearson's product-moment correlation coefficients. Partial correlations adjusted for age and sex were used to compare the relationships between obesity indices and metabolic risk factors. ANCOVA was used to adjust the means of metabolic risk factors for age and obesity indices. Separate analyses were performed for men and women due to possible differences in the effects of body size and body composition. Stepwise multiple regression analysis was performed to model the associations between metabolic risk factors and obesity indices, including age and sex as potential confounders. Although different obesity indices were highly correlated with each other (see Results) the colinearity diagnostics indicated that they could be used in the same multiple regression model. A P-value o0.05 was considered statistically significant. All analyses were conducted using SPSS for Windows software (SPSS Inc., Chicago, IL, USA). To evaluate the accuracy of obesity indices for assessment of metabolic risk, we calculated sensitivity (proportion of true positives, that is, cases correctly identified as meeting the condition MSX) and specificity (proportion of true negatives, i.e. proportion of cases correctly identified as not meeting the condition MSX) of obesity indices for creation of receiver operating characteristic (ROC) curves. The ROC curve is a plot of sensitivity (true positive fraction) vs 1Àspecificity (false positive fraction) for a predictor. The area under the ROC curve (AUC) provides a single measure of overall accuracy that is not dependent upon a particular threshold. For variables that positively predict the outcome (MSX), theoretical values of the AUC lie between 0.5 and 1.0 (with 1.0 representing perfect prediction). A value of 0.8 for the AUC means that for 80% of the time a random selection from the positive group will have a score greater than a random selection from the negative class. A web-based calculator for ROC curves was used. 
Results
Characterization of the study population Descriptive statistics of the 335 subjects (191 women and 144 men) are indicated in Table 1 . Age ranged between 28 and 84 years in women and 31 and 83 years in men. Sex differences were observed for %FM and HDL-C, with higher values in women. For WC, uric acid and systolic blood pressure (BPsys) higher values were found in men. About one-third of women and a quarter of men were obese, an additional proportion of 38% of women and 51% of men were overweight (Table 2 ). There was a high prevalence of morbidity: More than 40% of subjects were insulin resistant, about 60% had hypercholesterolemia and nearly one-third suffered from MSX ( Table 2) . Body fat mass in assessment of metabolic risk A Bosy-Westphal et al
Comparing subjects with MSX to subjects without MSX, there were no significant differences in age and cholesterol for males and CRP for both sexes (Table 3) . Mean values of all other metabolic risk factors, age and obesity indices were significantly higher and HDL-C was lower in subjects with MSX. In the MSX group, the mean values for BMI, %FM, WC and WC/ht indicated obesity. whereas in subjects without MSX the mean values of BMI and %FM were lower and corresponded to overweight or 'overfat', respectively (Table 3) . In both sexes all obesity indices were highly correlated with each other (Table 4 ). The correlations between BMI and the indices of central adiposity WC or WC/ht were closer than the correlations between BMI and general adiposity (%FM) for both men and women. Conversely, general adiposity is reflected equally well or even better by WC and WC/ht than by BMI in both sexes (Table 4) .
Evaluating %FM vs BMI and WC for assessment of obesity-related metabolic risk The associations between different obesity indices and metabolic risk factors are shown in Figure 1 as a plot of absolute values of correlation coefficients. Age-and sexadjusted coefficents of correlation between obesity indices and lnTG, HDL-C, HOMA-IR and uric acid are presented for both sexes combined in Table 5 . Comparing the strength of 
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A Bosy-Westphal et al correlations between obesity indices, different patterns were observed according to risk factor and sex ( Figure 1 ). In men no significant relations between cholesterol levels and obesity indices was found. %FM was more closely related to risk factors than BMI in six cases: lnTG in women, cholesterol in women, BPsys and CRP levels in both sexes (Figure 1 ). By contrast, in the remaining eight correlations, BMI performed equally well or better than %FM. When compared to indices of general adiposity (BMI or %FM), associations between indices of central obesity (WC or WC/ht) and metabolic risk factors are generally stronger, with the exception of cholesterol and BPsys in women, HDL-C in men and CRP levels in both sexes (Figure 1 ). In Figure 2, Body fat mass in assessment of metabolic risk A Bosy-Westphal et al indices were increasing with age, whereas in men this was only observed for WC/ht ( Table 4 ). The inclusion of sex and age into models of stepwise regression analysis (Table 6 ) identified significant age effects independent of body composition on cholesterol, HDL-C and glucose levels, and independent sex effects for HDL-C and BPsys. Comparing age-and obesity index-adjusted means of metabolic risk factors in men and women, sex differences consistently remained in levels of HDL-C and uric acid (data not shown). Sex differences were also observed in age-and obesity indexadjusted means of Bpsys, with the exception of adjusting BPsys for age, and WC values were no longer different between sexes (data not shown). By contrast, highly significant sex differences in TG levels were only observed after adjusting for age and %FM (97.0275.20 mg/dl in females and 140.5676.31 mg/dl in males, respectively; Po0.001).
Value of WC vs WC/ht for assessment of metabolic risk Discriminating between WC and WC/ht revealed a slightly closer association between WC/ht and metabolic risk in women (with the exception of HDL-C), while in men this was only observed for CRP levels (Figure 1 ).
Stepwise multiple regression analysis including sex, age and obesity indices as independent variables was used to identify the parameter that explains the highest variance in individual risk factors. In all models WC/ht reached the highest values of explained variance, except for CRP, where %FM was the main predictor, and HDL-C and uric acid, to which only WC contributed significantly in variance explanation (Table 6 ). However, the comparison of ROC curves revealed similar AUCs of WC/ht and WC in both sexes (Figure 2 ).
Plausibility of adjusting WC for height
There was a high correlation between height and FFM in both sexes combined (r ¼ 0.81, Po0.001) as well as separately in females and males (females r ¼ 0.65, males r ¼ 0. 
Discussion
Value of FM vs anthropometric obesity indices for assessment of metabolic risk
The main finding of our study was that %FM as a direct measure of adiposity has no advantage over indirect indices of obesity (BMI, WC) in the assessment of obesity-related metabolic risk. This observation is in line with previous studies, [8] [9] [10] [11] [12] but contrary to others. [13] [14] [15] However, in all these studies, [8] [9] [10] [11] [12] [13] [14] [15] %FM was determined by the use of bioelectrical impedance analysis. Thus, the inaccuracies of impedance measurements may add to the observed discrepancies. Since we used densitometry for body composition analysis, inaccuracies of field methods for body composition analysis cannot account for the lack of an advantage of %FM over BMI as an index of obesity-related health risk. This is in line with a previous study. In a comparable number of adult subjects from the Quebec Family Study, FM as assessed by under-water weighing also added little additional information to BMI with respect to cardiovascular disease risk factors in females. 33 Comparing the accuracy of MSX prediction by BMI, %FM or WC, the analysis of ROC curves revealed similar ROC areas for different obesity indices (Figure 2 ). This is in accordance with two other studies, showing that BMI, %FM, WC and WC/ht were equivalent in their ability to predict type II diabetes in Pima Indians. 11, 12 Taken together, all these results suggest that, at the population level, BMI is an adequate index of obesity-related metabolic risk that does not lag behind direct assessment of adiposity. However, this does not challenge the issue that indirect estimates of body composition are useful for groups but simultaneously unreliable in individuals.
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Measures of visceral or abdominal fat may exceed the value of BMI predicting components of MSX or MSX composite itself. Waist-to-hip circumference was the first index adopted as a measure of the abdominal location of body fat. [35] [36] [37] Imaging technologies identified WC as an suitable index of visceral FM. [38] [39] [40] In our study, indices of central obesity (WC/ ht in both sexes and WC in men) were more closely related to %FM than BMI (Table 4) . Additionally, when compared to %FM or BMI, both indices of central obesity (WC/ht in women and WC in men) were more closely associated with metabolic risk (Figure 1 ). This is in line with previous studies showing that when compared with other anthropometric obesity indices WC was the best predictor of metabolic risk. [16] [17] [18] [19] [20] However, reproducibility of WC measurements is considerably lower than that for BMI (see Methods). This may be a limitation for the detection of small intraindividual changes of WC in intervention studies and also for the estimation of health risk in an individual patient. The latter aspect is also complicated by the heterogenity of anatomical measurement sites (e.g. midpoint between the lowest rib and the iliac crest, as suggested by the WHO, or immediately above the iliac crest, as recommended by NIH guidelines and NHANES III) (see Wang et al. 41 for review).
Obesity-related health risk depends on the end points studied. For instance, the relation between BMI and cardiovascular mortality is weaker than the relation between BMI and diabetes or gall bladder disease. 42 In our study, we investigated the associations of different obesity indices with components of the MSX. Our data show that MSX is a composite of individual component traits, where each trait is differently associated with the obesity indices. The differences in the strength of correlations between an obesity index and individual risk factors exceeded the differences between different obesity indices within one risk factor (Figure 1 ). Although measures of central adiposity (WC, WC/ht) tended to show closer associations with risk factors than measures of general adiposity, the differences were small and depended on the type of risk factor and sex. From these results, we may deduce that in studies of comparably population size obesity indices can be used interchangeable for assessment of MSX components. Since two prospective studies have identified obesity as the central feature of the MSX, 43, 44 suggesting that obesity may precede the development of other components of the MSX, it is tempting to speculate that the definition of MSX by the NCEP that weights obesity equal to the other features of MSX might be more valid than the definition of the WHO that assigns IR a presupposition of MSX.
Plausibility of adjusting WC for height
In a stepwise multiple regression analysis, WC/ht was the main predictor of metabolic risk for men and women combined (Table 6 ). Additionally, when compared to WC, we observed higher correlations of WC/ht with %FM (Table 4) . This indicates that when compared to WC alone the advantage of WC/ht is a better index of body composition, that is, relative proportions of FM and consequently FFM. In fact, there was a high correlation between FFM and body height (see Results). Short height is also known to be associated with increased risk for coronary heart disease. Henriksson et al. 45 found that body height has an inverse relation to serum cholesterol and non-HDL cholesterol in middle-aged men, which was independent of BMI and waistto-hip ratio. Since FFM is known to have an inverse association with all-cause mortality, 46-48 the close association between WC/ht and metabolic risk in women ( Figure 1 ) and for both sexes combined (Table 6 ) might be explained by the relation of a risk factor ( ¼ WC) to a protecting and thus compensating parameter of body composition (i.e. FFM or muscle mass reflected by body height). This idea is supported by three lines of indirect evidence. First, like FFM, hip or thigh, circumferences have been shown to be inversely associated with health risk. 39, [49] [50] [51] [52] [53] [54] A greater lean mass in the nonabdominal region (i.e. a higher muscle mass in the gluteofemoral region) may explain the protective effect of a large hip or thigh circumference. Second, height partly explained the inverse associations of hip circumference with diabetes, dyslipidemia or hypertension. 55 Third, at a given WC, mortality rate ratio was shown to decrease with increasing BMI. 19, 20 This decrease was most pronounced at a lower WC and was weaker at higher WC. Thus, a protective effect of a high BMI at a given WC is likely to be due to a higher absolute amount of lean body mass in relation to visceral adipose tissue, as reflected by WC. A drawback of a simple ratio (i.e. waist-to-hip ratio (WC/ ht)) is that it cannot consider nonlinear relationships between hip and WC or height and WC, respectively. 56 The exponential character of the denominator WC 3 in the ratio FFM/WC 3 implies that at a given FFM with gradually increasing WC the increase in metabolic risk is lower than proportional. This is supported by the finding that small increases in intra-abdominal fat area are associated with larger reductions in insulin sensitivity when small amounts of intra-abdominal fat are present. By contrast, this effect quantitatively diminishes as intra-abdominal fat accumulates. 57 However, our empirical observation is derived from the best fit between FFM, WC and risk factors, and therefore any causal interpretation is preliminary and should be done with caution. We conclude that at the population level the measurement of body FM has no advantage over BMI and WC with respect to the prediction of obesity-related metabolic risk. Although measures of central adiposity (WC, WC/ht) tended to show closer associations with risk factors than measures of general adiposity, the differences were small and depended on type of risk factor and sex, suggesting an equivalent application of methods. Considering body components with a protective contribution to health risk (i.e. FFM or muscle mass) in combination with risk-associated components (i.e. visceral or abdominal FM) may result in an improved approach for assessment of obesity-related metabolic risk.
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